GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma
NCT05352542 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2024-08-09
Summary
A Phase I Clinical Trial for Evaluating the Safety, Tolerance and Efficacy of GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma
Conditions
Interventions
- BIOLOGICAL
-
GPC3 Targeting CART Cells
before treatment with GPC3 Targeting CART cells, subjects will receive a conditioning regimen
Sponsors & Collaborators
-
jianming xu
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-19
- Primary Completion
- 2024-07-31
- Completion
- 2024-07-31
Countries
- China
Study Locations
More Related Trials
-
Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors
NCT04951141 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma
NCT05620706 ·Status: RECRUITING ·Phase: NA
-
CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma
NCT06641453 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)
NCT03084380 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
NCT05926726 ·Status: RECRUITING ·Phase: NA
-
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
NCT05003895 ·Status: RECRUITING ·Phase: PHASE1
-
GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC
NCT04121273 ·Status: UNKNOWN ·Phase: PHASE1
-
4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3
NCT03980288 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
NCT06968195 ·Status: SUSPENDED ·Phase: PHASE1
-
Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer
NCT06653023 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma
NCT03349255 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
NCT06144385 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
NCT07039201 ·Status: RECRUITING ·Phase: NA
-
Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)
NCT03062358 ·Status: COMPLETED ·Phase: PHASE3
-
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
NCT06560827 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)
NCT06590246 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer
NCT05323201 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3
NCT05738980 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma
NCT03633773 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma
NCT05070156 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma
NCT03993743 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
NCT02959151 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC
NCT03672305 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
NCT01507168 ·Status: COMPLETED ·Phase: PHASE2
-
Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma
NCT05845502 ·Status: TERMINATED ·Phase: NA